Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder in children, with worldwide prevalence of ADHD varying from 5.9 to 7.1 %, depending on the reporter. In case of inadequate response to stimulants, combination therapy of stimulants and an adjunctive medication may improve the control of ADHD symptoms, reduce the dose-limiting adverse events, and help control comorbidities. To date, the only medication to be used for adjunctive therapy to psychostimulants is guanfacine extended release (GXR). The aim of this study was to assess the economic impact of GXR as an adjunct therapy with long-acting stimulants (GXR + stimulant) compared to long-acting stimulant monotherapy (stimulant alone) in the treatment of children and adolescents with ADHD in Canada. A Markov model was developed using health states defined based on the clinician-reported Clinical Global Impression-Severity (CGI-S) score (normal, mild, moderate, severe). Transition probabilities were calculated based on patient-level data from a published study. Long-acting stimulants available in Canada were considered in the base-case model: amphetamine mixed salts, methylphenidate HCl formulations, and lisdexamfetamine dimesylate. Analyses were cond...Continue Reading
References
Jan 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·J BiedermanJ Soriano
Sep 18, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·S MannuzzaM E Hynes
Jul 4, 2001·Pediatrics·J GuevaraH Gephart
Aug 14, 2001·Pharmacoepidemiology and Drug Safety·A Gilmore, R Milne
Apr 8, 2003·CNS Spectrums·Steven R Pliszka
Jun 27, 2006·Health Technology Assessment : HTA·S KingR Riemsma
Sep 14, 2006·Current Psychiatry Reports·Lenard A AdlerTimothy E Wilens
May 8, 2007·European Child & Adolescent Psychiatry·L Hakkaart-van RoijenJ K Buitelaar
Jul 3, 2009·International Journal of Clinical Practice·S PrasadS E Libretto
Nov 3, 2009·Journal of Child and Adolescent Psychopharmacology·Thomas J SpencerWilliam Rory Murphy
Oct 15, 2011·The Patient·Andrew LloydJohn Brazier
Dec 20, 2011·Journal of the American Academy of Child and Adolescent Psychiatry·Timothy E WilensSharon Youcha
Feb 22, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Marie-Christine Brault, Éric Lacourse
Jun 14, 2012·Postgraduate Medicine·Jean LachainePaul S Hodgkins
Jun 21, 2012·CNS Drugs·Lyn ColvinCarol Bower
Jul 4, 2012·International Archives of Occupational and Environmental Health·Thomas KüpperBarbara Schauble
Jul 14, 2012·PharmacoEconomics·Vanja SikiricaEric Q Wu
Sep 15, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Erik G Willcutt
Oct 2, 2012·Journal of the American Academy of Child and Adolescent Psychiatry·Jalpa A DoshiPeter J Neumann
Sep 6, 2013·Journal of Medical Economics·Juliana SetyawanM Haim Erder
Jan 10, 2014·CNS Drugs·Ann C Childress, Floyd R Sallee
Jan 8, 2015·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jean LachaineLeila Ben Amor
Citations
Jan 26, 2017·Journal of Comparative Effectiveness Research·Juliana MeyersVanja Sikirica
Aug 23, 2019·Journal of Child and Adolescent Psychopharmacology·Jean LachaineJudy van Stralen
Mar 3, 2020·Frontiers in Psychiatry·Anne BerghöferBarbara Stöckigt
Mar 23, 2021·European Child & Adolescent Psychiatry·Filipa SampaioNorbert Skokauskas
Oct 28, 2021·Journal of Child and Adolescent Psychopharmacology·Hermien H DijkAnnabeth P Groenman